TP53 and lung cancer: Interestingly, we outlined the co-mutational status of these beneficial and noxious genes with TP53 in lung cancer and found a significantly different status of co-mutated DNA damage repair genes was detected in the TP53mut cohort, which may be related to better immune checkpoint inhibitor response and prognosis.